New drug combo shows promise for rare blood disorder
Disease control
Completed
This phase 2 trial tested whether adding luspatercept to standard cyclosporine treatment helps people with non-severe aplastic anemia. The study enrolled 58 newly diagnosed adults who had low blood counts but did not yet need transfusions. The goal was to see if the combination c…
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC